Stacy Lynn Hollandsworth, INTERN | |
2400 S 48th St, Springdale, AR 72762-6683 | |
(479) 750-2020 | |
(479) 750-8967 |
Full Name | Stacy Lynn Hollandsworth |
---|---|
Gender | Female |
Speciality | Counselor |
Location | 2400 S 48th St, Springdale, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053569491 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stacy Lynn Hollandsworth, INTERN Po Box 6430, Springdale, AR 72766-6430 Ph: (479) 750-2020 | Stacy Lynn Hollandsworth, INTERN 2400 S 48th St, Springdale, AR 72762-6683 Ph: (479) 750-2020 |
News Archive
Mathematical models analyzing how a cholera outbreak spread in Zimbabwe are providing new insights into the most effective vaccination strategies for preventing future cholera epidemics, according to University of Florida researchers.
West Coast University has announced that the Dental Hygiene Clinic at its Anaheim campus will offer the public free dental hygiene services ranging from oral inspection and risk assessment, to digital and traditional imaging (X-rays), to preventative therapies and non-surgical periodontal therapy (cleanings).
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same", U.S. Patent No. 7,776,917 B2. This patent, combined with KemPharm's recently issued U.S. Patent No. 7,772,222, provides broad protection of the Company's Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.
One-third of patients who have survived a life-threatening subarachnoid hemorrhage (SAH) have disabling symptoms of posttraumatic stress disorder (PTSD), reports a study in the August issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Chugai Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by Chugai, for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors, administered once weekly, every two weeks, or every four weeks.
› Verified 2 days ago
Brenda Joyce Hill, MHPP Counselor Medicare: Not Enrolled in Medicare Practice Location: 2400 S 48th St, Springdale, AR 72762 Phone: 479-750-2020 Fax: 479-750-8967 | |
Leah Nicole Finn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2400 S 48th St, Springdale, AR 72762 Phone: 479-750-2020 Fax: 479-750-8967 | |
Michael Patrick Leonard, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2400 S 48th St, Springdale, AR 72762 Phone: 479-750-2020 Fax: 479-750-4843 | |
Alana Nicole Linn, LMSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 2400 S 48th St, Springdale, AR 72762 Phone: 479-750-2020 Fax: 479-750-4843 | |
Beverly Ann Treat, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5537 Bleaux Ave, Springdale, AR 72762 Phone: 870-448-4727 Fax: 870-448-4496 | |
Jason Adams, MHPP Counselor Medicare: Not Enrolled in Medicare Practice Location: 2400 S 48th St, Springdale, AR 72762 Phone: 479-750-2020 Fax: 479-750-8967 | |
Lance Gregory Johnson, MHPP Counselor Medicare: Not Enrolled in Medicare Practice Location: 2400 S 48th St, Springdale, AR 72762 Phone: 479-750-2020 Fax: 479-750-8967 |